Proof-of-Concept of A DNA-Based Recording System for High-Throughput Functional Gene Screening
Kato, S.; Ikemoto, A.; Isayama, J.; Takimoto, T.; Saya, H.; Hamada, K.-i.
Show abstract
Pooled genetic screening technologies offer high efficiency and enable systematic causal analyses. However, further reductions in cost and handling complexity are still desirable. Here we present PiER (Perturbation-induced Intracellular Events Recorder), a novel streamlined pooled genetic screening technology that couples gene perturbation with intracellular signal recording and does not require single-cell isolation, cell sorting, or survival selection. PiER consists of three DNA domains: a Perturbation domain that introduces gene-specific perturbations; a Response domain that expresses a site-specific recombinase when a chosen signaling pathway is activated; and a Memory domain whose sequence is permanently rewritten by the recombinase, storing perturbation-response histories in situ. In HEK293 cells, a WNT-responsive Response/Memory domain construct produced dose-dependent recombination signatures verified by a fluorescent reporter and quantitative PCR. Lentiviral delivery of a pooled shRNA PiER library subsequently identified WNT-related shRNA candidates. PiER thus provides a versatile, scalable tool for functional genomics and drug-target discovery.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Cell type specific long non-coding RNA targets identified by integrative analysis of single-cell and bulk colorectal cancer transcriptomes 94%
- Synthetic Circuits Based On Split Cas9 To Detect Cellular Events 94%
- Rgen-Seq For Highly Sensitive Amplification-Free Screen Of Off-Target Sites Of Gene Editors 93%
Similar papers in this journal
Similar papers in this journal
- An aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout for allogeneic CAR-T cells generation 92%
- A functional screening platform for engineering chimeric antigen receptors with reduced on-target, off-tumour activation 92%
- Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer 92%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.